{
  "paper_metadata": {
    "pmid": "38015761",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the KCNH2 gene variant A561V, including penetrance data and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1682A>G",
      "protein_notation": "p.Ala561Val",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "not specified",
        "phenotype": "Long QT syndrome"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 25,
          "age_at_onset": 20,
          "age_at_diagnosis": 22,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "experienced syncope and palpitations",
          "evidence_sentence": "The patient P1 was diagnosed with Long QT syndrome at age 22."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "had a cardiac arrest episode",
          "evidence_sentence": "Patient P2 had a cardiac arrest episode at age 28."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 18,
          "age_at_onset": null,
          "age_at_diagnosis": 18,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms reported",
          "evidence_sentence": "Patient P3 is a carrier but remains asymptomatic."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 40,
          "age_at_onset": 35,
          "age_at_diagnosis": 36,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed after family screening",
          "evidence_sentence": "Patient P4 was diagnosed after family screening at age 36."
        }
      ],
      "functional_data": {
        "summary": "The A561V mutation leads to reduced KCNH2 protein expression and activates the unfolded protein response.",
        "assays": [
          "Western blotting",
          "reverse transcription-quantitative PCR",
          "immunofluorescence",
          "immuno-coprecipitation",
          "mass spectrometry"
        ]
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study provides insights into the functional impact of the A561V mutation on KCNH2 protein expression.",
      "key_quotes": [
        "The A561V-KCNH2 mutation leading to the accumulation of the immature form of KCNH2.",
        "These results provided a theoretical basis for clinical treatment of Long QT syndrome."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}